UBS Trims Legacy Liabilities and Exits Fund Servicing as Swiss Liquidity Levy Takes Shape
Published on 10/14/2026 at 05:51 | Editorial boerse-global.de
UBS closed Tuesday's European session at EUR 42.77, a level that leaves the stock up 7.5% since the start of the year and 4.8% above its 200-day moving average of EUR 40.82. The shares remain 11% short of their 52-week high of EUR 48.19, a gap that captures the tug-of-war now defining the Swiss lender's investment case: improving operating momentum on one side, an increasingly UBS-specific regulatory burden on the other.
Balance sheet housekeeping ahead of the quarterly print
The bank is using existing call options to retire all of its outstanding senior callable notes, a JPY 8.3 billion tranche originally dated to 2027 and carrying a 0.904% coupon. Redemption is set for 27 October 2026 — one day before third-quarter results — giving market participants a cleaner read on the group's future interest and cost structure.
A separate move reshapes the business mix. On 6 October, UBS agreed with Northern Trust to broaden their fund administration partnership, transferring the Luxembourg and Swiss fund servicing operations formerly run by Credit Suisse. The deal, subject to regulatory approvals, is expected to close in the second quarter of 2027 and marks a full exit from the segment.
Deutsche Bank raises the bar
Analyst Benjamin Goy at Deutsche Bank Research lifted his price target on 7 October to CHF 47 from CHF 45 while keeping a Buy rating. His team projects third-quarter pre-tax profit 23% above the year-earlier figure, and describes the Credit Suisse integration as a key driver of return on equity in 2027. The stock has added 1.1% since that assessment roughly a week ago.
The operating record supports the optimism. Second-quarter 2026 earnings per share climbed to CHF 0.72 from CHF 0.62 a year earlier, and consensus points to full-year 2026 EPS of USD 3.63. Shareholders may also see a marked dividend step-up, with the payout projected to rise to USD 1.26 per share from CHF 0.86.
Should investors sell immediately? Or is it worth buying UBS?
A levy written for one bank
What clouds that picture sits in Bern. On Tuesday, the economic committee of the Swiss Council of States voted nine to zero, with three abstentions, to enshrine the public liquidity backstop in permanent law and attach an ex-ante fee to it. The instrument was created by emergency decree during the spring 2023 crisis; the committee now wants to restrict the financial charge to systemically important institutions with significant international operations — a definition that, as things stand, captures UBS alone.
The Swiss Bankers Association opposes the plan, warning of competitive disadvantages and calling it discriminatory. UBS declined to comment.
How the fee is calculated matters as much as its existence. Rather than a flat charge, the committee proposes tying the ex-ante compensation to specific balance sheet items: loss-absorbing debt instruments, collateral held with foreign central banks, and long-term refinancing sources such as Pfandbriefe and covered bonds. Each of those touches the group's funding architecture directly, and a permanent charge on state liquidity provision would weigh on net interest margin. The profitability of the international franchise therefore hinges on how tightly or loosely lawmakers draw the parameters.
Management weighs its options
Regulatory pressure has reportedly pushed the leadership into broader deliberations. According to Reuters, citing the Financial Times, UBS is examining ways to reduce its exposure to Swiss rules, including a possible merger with a foreign bank. The company declined to comment on that report.
UBS had previously cautioned that parliamentary steps toward stricter capital requirements could translate into materially higher capital demands. With the full Council of States debate not due until the winter session, investors must price in another regulatory unknown.
Two clocks running at once
The near-term test arrives on 28 October 2026, when UBS publishes third-quarter 2026 figures. The release will show how the market environment has fed through to net interest income and the cost base — and whether operating growth is sufficient to absorb the regulatory costs that may lie ahead. Should the winter session deliver a hard ex-ante fee with no carve-outs for the bank, estimates for 2027 and beyond face sustained pressure; if capital generation stays on consensus, the political noise is unlikely to knock the shares off course for now.
Ad
UBS Stock: New Analysis - 14 October
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
